104 related articles for article (PubMed ID: 9934759)
21. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
[TBL] [Abstract][Full Text] [Related]
22. Failure of immunosuppressive therapy to prevent relapse of celiac sprue.
Duerksen DR; Ma MM; Jewell LD
J Clin Gastroenterol; 1995 Oct; 21(3):255-7. PubMed ID: 8648066
[No Abstract] [Full Text] [Related]
23. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
Christodoulou D; Katsanos K; Baltayannis G; Tzabouras N; Tsianos EV
Hepatogastroenterology; 2003; 50(52):1021-4. PubMed ID: 12845970
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2-year prospective study.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W; Inchingolo CD; Monardo E; Aiello F
Endoscopy; 2006 Jul; 38(7):702-7. PubMed ID: 16810593
[TBL] [Abstract][Full Text] [Related]
25. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal.
Tursi A; Brandimarte G; Giorgetti G
Am J Gastroenterol; 2003 Apr; 98(4):839-43. PubMed ID: 12738465
[TBL] [Abstract][Full Text] [Related]
27. TNF-alpha antibody treatment in refractory collagenous sprue: report of a case and review of the literature.
Schmidt C; Kasim E; Schlake W; Gerken G; Giese T; Stallmach A
Z Gastroenterol; 2009 Jun; 47(6):575-8. PubMed ID: 19533547
[TBL] [Abstract][Full Text] [Related]
28. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
[TBL] [Abstract][Full Text] [Related]
29. Multimodal immunosuppressant therapy in steroid-refractory common variable immunodeficiency sprue: a case report complicating cytomegalovirus infection.
Medlicott SA; Coderre S; Horne G; Panaccione R
Int J Surg Pathol; 2006 Jan; 14(1):101-6. PubMed ID: 16501846
[TBL] [Abstract][Full Text] [Related]
30. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease.
Kaukinen K; Peräaho M; Lindfors K; Partanen J; Woolley N; Pikkarainen P; Karvonen AL; Laasanen T; Sievänen H; Mäki M; Collin P
Aliment Pharmacol Ther; 2007 May; 25(10):1237-45. PubMed ID: 17451570
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
32. Refractory celiac disease.
Ryan BM; Kelleher D
Gastroenterology; 2000 Jul; 119(1):243-51. PubMed ID: 10889175
[TBL] [Abstract][Full Text] [Related]
33. [Qualitative and quantitative nature of inflammatory infiltrations during treatment of coelic sprue: correlation with the clinical and histological picture (author's transl)].
Giacosa A; Cheli R
Cesk Gastroenterol Vyz; 1980 May; 34(3):145-50. PubMed ID: 7388985
[No Abstract] [Full Text] [Related]
34. [Intestinal biopsy findings in a case of native sprue before and after treatment with folic acid].
Astaldi G; Penna R; Ceretto F
Minerva Med; 1966 Oct; 57(81):3290-6. PubMed ID: 5955195
[No Abstract] [Full Text] [Related]
35. Successful treatment of atypical sprue in an infant with cyclosporine.
Bernstein EF; Whitington PF
Gastroenterology; 1988 Jul; 95(1):199-204. PubMed ID: 3371614
[TBL] [Abstract][Full Text] [Related]
36. The histologic spectrum and clinical outcome of refractory and unclassified sprue.
Robert ME; Ament ME; Weinstein WM
Am J Surg Pathol; 2000 May; 24(5):676-87. PubMed ID: 10800986
[TBL] [Abstract][Full Text] [Related]
37. [Biopsy of the duodenum in sprue].
Cheli R
Arch Fr Mal App Dig; 1969; 58(4):245-8. PubMed ID: 5399967
[No Abstract] [Full Text] [Related]
38. Refractory sprue.
Culliford AN; Green PH
Curr Gastroenterol Rep; 2003 Oct; 5(5):373-8. PubMed ID: 12959717
[TBL] [Abstract][Full Text] [Related]
39. Undefined malabsorption syndrome with villous atrophy successfully reversed by treatment with cyclosporine.
Eijsbouts AM; Witteman BJ; de Sévaux RG; Fennis JF; van Haelst UJ; Naber AH; Jansen JB
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):803-6. PubMed ID: 7496873
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of refractory sprue with cyclosporine.
Longstreth GF
Ann Intern Med; 1993 Nov; 119(10):1014-6. PubMed ID: 8214978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
